Skip to main content

ARISTEIA CAPITAL, L.L.C.

Position in EBS — Emergent BioSolutions Inc.

CIK 1080171 GREENWICH, CT

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,355,490
+$1,010,041 QoQ
Shares Held
161,753
+478.7% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#43
of 194 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ARISTEIA CAPITAL, L.L.C. holds $2,835,729 across 4 Drug Manufacturers - Specialty & Generic names. EBS ranks #1 (47.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EBS
Emergent BioSolutions Inc.
This page
161,753 $1,355,490

All Filings in EBS

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,355,490 161,753
2025-12-31 $345,449 27,949
2025-06-30 $955,066 149,697
2024-12-31 $384,034 40,171
2024-06-30 $642,191 94,163
2024-03-31 $366,313 144,788